MED RES REV 润色咨询

MEDICINAL RESEARCH REVIEWS

出版年份：1981 年文章数：656 投稿命中率： 开通期刊会员，数据随心看

出版周期：Bimonthly 自引率：0.5% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1183540, encodeId=4669118354067, content=11月份投稿，一直到现在都是“In review”的状态。这个杂志是没有其他状态吗？还是就是这么慢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=31, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c0bc2138901, createdName=bpwen1989, createdTime=Wed Jan 12 15:25:17 CST 2022, time=2022-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097879, encodeId=0dec209e8792c, content=9月9号投稿，马上三个月了，一直是In review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230421/adeb33fe5b714f0a8fb577ba825f7c91/e882373f4e104adeae042dac78711c17.jpg, createdBy=ea1a1836331, createdName=ms1023144545986451, createdTime=Tue Nov 01 17:00:20 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116737, encodeId=379b2116e37c6, content=审稿速度:12.0 | 投稿命中率:5.0<br>经验分享：今天有消息了 ，刚好9个月，告诉我他们期刊这几年审稿压力很大，稿件量是三倍，还是没办法保证我的审稿，让我转投一个4分的期刊。大家慎重考虑此刊吧。<br>时间：投稿是2022年5月26日，在三个月、半年的时候分别催稿，第二次催稿回复我说文章正在外审，现在第9个月告诉我审不了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2745723606, createdName=ms5000000402047516, createdTime=Mon Feb 27 17:17:20 CST 2023, time=2023-02-27, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1241122, encodeId=aec712411227c, content=有没有投了被拒的，多长时间被拒？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201020/ab7dee8018d2436d9c185605ca6df4d1/259e5aca63734597994109f6badb5036.jpg, createdBy=e5255379558, createdName=丿柚子, createdTime=Fri Aug 26 11:01:31 CST 2022, time=2022-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233690, encodeId=286c123369024, content=两个月了还是in review , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af6a5287300, createdName=14856b50m82暂无昵称, createdTime=Wed Jul 20 20:44:37 CST 2022, time=2022-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2140610, encodeId=76cf214061019, content=审稿速度:24.0 | 投稿命中率:5.0<br>偏重的研究方向：心血管<br>经验分享：投稿9个多月，中间催稿三次，最后拒稿，说稿量太大，处理不过来，真是无语。搞不懂为何不早点拒稿，浪费别人时间，不建议投此期刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4e875572837, createdName=ms7000000342226604, createdTime=Sat Jun 03 10:46:59 CST 2023, time=2023-06-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1228408, encodeId=36c21228408c0, content=in review时间很长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbcb5705258, createdName=ms6000002029762274, createdTime=Fri Jun 24 12:03:23 CST 2022, time=2022-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127488, encodeId=4a3b212e488e4, content=2022年9月9号投稿，马上八个月了，还没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230421/adeb33fe5b714f0a8fb577ba825f7c91/e882373f4e104adeae042dac78711c17.jpg, createdBy=ea1a1836331, createdName=Lucky2023 , createdTime=Fri Apr 21 15:15:54 CST 2023, time=2023-04-21, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2115920, encodeId=6069211592029, content=审稿速度:12.0 | 投稿命中率:5.0<br>经验分享：2022年5月投稿，到现在9个月了，还是没有一审意见，这个期刊初审是不是要一整年啊，无语了，新的文章都已经发了好几篇了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2745723606, createdName=ms5000000402047516, createdTime=Wed Feb 22 14:05:24 CST 2023, time=2023-02-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2130098, encodeId=8ca42130098d2, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向：肿瘤;药理<br>经验分享：选刊比投稿更重要, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epmic7Il9IdkhKdPslSXbzCGyicssZvlek5wZt8vgWkKYUiabEWuAc0BmYZoYNFG8B7eCQdkia06oqnkQ/132, createdBy=c38f2021744, createdName=小舞SCI, createdTime=Thu May 04 19:54:03 CST 2023, time=2023-05-04, status=1, ipAttribution=江苏省)]
    2022-01-12 bpwen1989

    11月份投稿，一直到现在都是“In review”的状态。这个杂志是没有其他状态吗？还是就是这么慢？

    31

    展开31条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=1183540, encodeId=4669118354067, content=11月份投稿，一直到现在都是“In review”的状态。这个杂志是没有其他状态吗？还是就是这么慢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=31, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c0bc2138901, createdName=bpwen1989, createdTime=Wed Jan 12 15:25:17 CST 2022, time=2022-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097879, encodeId=0dec209e8792c, content=9月9号投稿，马上三个月了，一直是In review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230421/adeb33fe5b714f0a8fb577ba825f7c91/e882373f4e104adeae042dac78711c17.jpg, createdBy=ea1a1836331, createdName=ms1023144545986451, createdTime=Tue Nov 01 17:00:20 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116737, encodeId=379b2116e37c6, content=审稿速度:12.0 | 投稿命中率:5.0<br>经验分享：今天有消息了 ，刚好9个月，告诉我他们期刊这几年审稿压力很大，稿件量是三倍，还是没办法保证我的审稿，让我转投一个4分的期刊。大家慎重考虑此刊吧。<br>时间：投稿是2022年5月26日，在三个月、半年的时候分别催稿，第二次催稿回复我说文章正在外审，现在第9个月告诉我审不了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2745723606, createdName=ms5000000402047516, createdTime=Mon Feb 27 17:17:20 CST 2023, time=2023-02-27, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1241122, encodeId=aec712411227c, content=有没有投了被拒的，多长时间被拒？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201020/ab7dee8018d2436d9c185605ca6df4d1/259e5aca63734597994109f6badb5036.jpg, createdBy=e5255379558, createdName=丿柚子, createdTime=Fri Aug 26 11:01:31 CST 2022, time=2022-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233690, encodeId=286c123369024, content=两个月了还是in review , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af6a5287300, createdName=14856b50m82暂无昵称, createdTime=Wed Jul 20 20:44:37 CST 2022, time=2022-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2140610, encodeId=76cf214061019, content=审稿速度:24.0 | 投稿命中率:5.0<br>偏重的研究方向：心血管<br>经验分享：投稿9个多月，中间催稿三次，最后拒稿，说稿量太大，处理不过来，真是无语。搞不懂为何不早点拒稿，浪费别人时间，不建议投此期刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4e875572837, createdName=ms7000000342226604, createdTime=Sat Jun 03 10:46:59 CST 2023, time=2023-06-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1228408, encodeId=36c21228408c0, content=in review时间很长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbcb5705258, createdName=ms6000002029762274, createdTime=Fri Jun 24 12:03:23 CST 2022, time=2022-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127488, encodeId=4a3b212e488e4, content=2022年9月9号投稿，马上八个月了，还没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230421/adeb33fe5b714f0a8fb577ba825f7c91/e882373f4e104adeae042dac78711c17.jpg, createdBy=ea1a1836331, createdName=Lucky2023 , createdTime=Fri Apr 21 15:15:54 CST 2023, time=2023-04-21, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2115920, encodeId=6069211592029, content=审稿速度:12.0 | 投稿命中率:5.0<br>经验分享：2022年5月投稿，到现在9个月了，还是没有一审意见，这个期刊初审是不是要一整年啊，无语了，新的文章都已经发了好几篇了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2745723606, createdName=ms5000000402047516, createdTime=Wed Feb 22 14:05:24 CST 2023, time=2023-02-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2130098, encodeId=8ca42130098d2, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向：肿瘤;药理<br>经验分享：选刊比投稿更重要, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epmic7Il9IdkhKdPslSXbzCGyicssZvlek5wZt8vgWkKYUiabEWuAc0BmYZoYNFG8B7eCQdkia06oqnkQ/132, createdBy=c38f2021744, createdName=小舞SCI, createdTime=Thu May 04 19:54:03 CST 2023, time=2023-05-04, status=1, ipAttribution=江苏省)]
    2022-11-01 ms1023144545986451

    9月9号投稿，马上三个月了，一直是In review

    9

    展开9条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=1183540, encodeId=4669118354067, content=11月份投稿，一直到现在都是“In review”的状态。这个杂志是没有其他状态吗？还是就是这么慢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=31, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c0bc2138901, createdName=bpwen1989, createdTime=Wed Jan 12 15:25:17 CST 2022, time=2022-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097879, encodeId=0dec209e8792c, content=9月9号投稿，马上三个月了，一直是In review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230421/adeb33fe5b714f0a8fb577ba825f7c91/e882373f4e104adeae042dac78711c17.jpg, createdBy=ea1a1836331, createdName=ms1023144545986451, createdTime=Tue Nov 01 17:00:20 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116737, encodeId=379b2116e37c6, content=审稿速度:12.0 | 投稿命中率:5.0<br>经验分享：今天有消息了 ，刚好9个月，告诉我他们期刊这几年审稿压力很大，稿件量是三倍，还是没办法保证我的审稿，让我转投一个4分的期刊。大家慎重考虑此刊吧。<br>时间：投稿是2022年5月26日，在三个月、半年的时候分别催稿，第二次催稿回复我说文章正在外审，现在第9个月告诉我审不了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2745723606, createdName=ms5000000402047516, createdTime=Mon Feb 27 17:17:20 CST 2023, time=2023-02-27, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1241122, encodeId=aec712411227c, content=有没有投了被拒的，多长时间被拒？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201020/ab7dee8018d2436d9c185605ca6df4d1/259e5aca63734597994109f6badb5036.jpg, createdBy=e5255379558, createdName=丿柚子, createdTime=Fri Aug 26 11:01:31 CST 2022, time=2022-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233690, encodeId=286c123369024, content=两个月了还是in review , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af6a5287300, createdName=14856b50m82暂无昵称, createdTime=Wed Jul 20 20:44:37 CST 2022, time=2022-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2140610, encodeId=76cf214061019, content=审稿速度:24.0 | 投稿命中率:5.0<br>偏重的研究方向：心血管<br>经验分享：投稿9个多月，中间催稿三次，最后拒稿，说稿量太大，处理不过来，真是无语。搞不懂为何不早点拒稿，浪费别人时间，不建议投此期刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4e875572837, createdName=ms7000000342226604, createdTime=Sat Jun 03 10:46:59 CST 2023, time=2023-06-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1228408, encodeId=36c21228408c0, content=in review时间很长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbcb5705258, createdName=ms6000002029762274, createdTime=Fri Jun 24 12:03:23 CST 2022, time=2022-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127488, encodeId=4a3b212e488e4, content=2022年9月9号投稿，马上八个月了，还没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230421/adeb33fe5b714f0a8fb577ba825f7c91/e882373f4e104adeae042dac78711c17.jpg, createdBy=ea1a1836331, createdName=Lucky2023 , createdTime=Fri Apr 21 15:15:54 CST 2023, time=2023-04-21, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2115920, encodeId=6069211592029, content=审稿速度:12.0 | 投稿命中率:5.0<br>经验分享：2022年5月投稿，到现在9个月了，还是没有一审意见，这个期刊初审是不是要一整年啊，无语了，新的文章都已经发了好几篇了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2745723606, createdName=ms5000000402047516, createdTime=Wed Feb 22 14:05:24 CST 2023, time=2023-02-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2130098, encodeId=8ca42130098d2, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向：肿瘤;药理<br>经验分享：选刊比投稿更重要, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epmic7Il9IdkhKdPslSXbzCGyicssZvlek5wZt8vgWkKYUiabEWuAc0BmYZoYNFG8B7eCQdkia06oqnkQ/132, createdBy=c38f2021744, createdName=小舞SCI, createdTime=Thu May 04 19:54:03 CST 2023, time=2023-05-04, status=1, ipAttribution=江苏省)]
    2023-02-27 ms5000000402047516 来自福建省

    审稿速度:12.0 | 投稿命中率:5.0
    经验分享：今天有消息了 ，刚好9个月，告诉我他们期刊这几年审稿压力很大，稿件量是三倍，还是没办法保证我的审稿，让我转投一个4分的期刊。大家慎重考虑此刊吧。
    时间：投稿是2022年5月26日，在三个月、半年的时候分别催稿，第二次催稿回复我说文章正在外审，现在第9个月告诉我审不了。

    7

    展开7条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=1183540, encodeId=4669118354067, content=11月份投稿，一直到现在都是“In review”的状态。这个杂志是没有其他状态吗？还是就是这么慢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=31, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c0bc2138901, createdName=bpwen1989, createdTime=Wed Jan 12 15:25:17 CST 2022, time=2022-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097879, encodeId=0dec209e8792c, content=9月9号投稿，马上三个月了，一直是In review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230421/adeb33fe5b714f0a8fb577ba825f7c91/e882373f4e104adeae042dac78711c17.jpg, createdBy=ea1a1836331, createdName=ms1023144545986451, createdTime=Tue Nov 01 17:00:20 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116737, encodeId=379b2116e37c6, content=审稿速度:12.0 | 投稿命中率:5.0<br>经验分享：今天有消息了 ，刚好9个月，告诉我他们期刊这几年审稿压力很大，稿件量是三倍，还是没办法保证我的审稿，让我转投一个4分的期刊。大家慎重考虑此刊吧。<br>时间：投稿是2022年5月26日，在三个月、半年的时候分别催稿，第二次催稿回复我说文章正在外审，现在第9个月告诉我审不了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2745723606, createdName=ms5000000402047516, createdTime=Mon Feb 27 17:17:20 CST 2023, time=2023-02-27, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1241122, encodeId=aec712411227c, content=有没有投了被拒的，多长时间被拒？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201020/ab7dee8018d2436d9c185605ca6df4d1/259e5aca63734597994109f6badb5036.jpg, createdBy=e5255379558, createdName=丿柚子, createdTime=Fri Aug 26 11:01:31 CST 2022, time=2022-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233690, encodeId=286c123369024, content=两个月了还是in review , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af6a5287300, createdName=14856b50m82暂无昵称, createdTime=Wed Jul 20 20:44:37 CST 2022, time=2022-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2140610, encodeId=76cf214061019, content=审稿速度:24.0 | 投稿命中率:5.0<br>偏重的研究方向：心血管<br>经验分享：投稿9个多月，中间催稿三次，最后拒稿，说稿量太大，处理不过来，真是无语。搞不懂为何不早点拒稿，浪费别人时间，不建议投此期刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4e875572837, createdName=ms7000000342226604, createdTime=Sat Jun 03 10:46:59 CST 2023, time=2023-06-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1228408, encodeId=36c21228408c0, content=in review时间很长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbcb5705258, createdName=ms6000002029762274, createdTime=Fri Jun 24 12:03:23 CST 2022, time=2022-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127488, encodeId=4a3b212e488e4, content=2022年9月9号投稿，马上八个月了，还没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230421/adeb33fe5b714f0a8fb577ba825f7c91/e882373f4e104adeae042dac78711c17.jpg, createdBy=ea1a1836331, createdName=Lucky2023 , createdTime=Fri Apr 21 15:15:54 CST 2023, time=2023-04-21, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2115920, encodeId=6069211592029, content=审稿速度:12.0 | 投稿命中率:5.0<br>经验分享：2022年5月投稿，到现在9个月了，还是没有一审意见，这个期刊初审是不是要一整年啊，无语了，新的文章都已经发了好几篇了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2745723606, createdName=ms5000000402047516, createdTime=Wed Feb 22 14:05:24 CST 2023, time=2023-02-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2130098, encodeId=8ca42130098d2, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向：肿瘤;药理<br>经验分享：选刊比投稿更重要, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epmic7Il9IdkhKdPslSXbzCGyicssZvlek5wZt8vgWkKYUiabEWuAc0BmYZoYNFG8B7eCQdkia06oqnkQ/132, createdBy=c38f2021744, createdName=小舞SCI, createdTime=Thu May 04 19:54:03 CST 2023, time=2023-05-04, status=1, ipAttribution=江苏省)]
    2022-08-26 丿柚子

    有没有投了被拒的，多长时间被拒？

    7

    展开7条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=1183540, encodeId=4669118354067, content=11月份投稿，一直到现在都是“In review”的状态。这个杂志是没有其他状态吗？还是就是这么慢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=31, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c0bc2138901, createdName=bpwen1989, createdTime=Wed Jan 12 15:25:17 CST 2022, time=2022-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097879, encodeId=0dec209e8792c, content=9月9号投稿，马上三个月了，一直是In review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230421/adeb33fe5b714f0a8fb577ba825f7c91/e882373f4e104adeae042dac78711c17.jpg, createdBy=ea1a1836331, createdName=ms1023144545986451, createdTime=Tue Nov 01 17:00:20 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116737, encodeId=379b2116e37c6, content=审稿速度:12.0 | 投稿命中率:5.0<br>经验分享：今天有消息了 ，刚好9个月，告诉我他们期刊这几年审稿压力很大，稿件量是三倍，还是没办法保证我的审稿，让我转投一个4分的期刊。大家慎重考虑此刊吧。<br>时间：投稿是2022年5月26日，在三个月、半年的时候分别催稿，第二次催稿回复我说文章正在外审，现在第9个月告诉我审不了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2745723606, createdName=ms5000000402047516, createdTime=Mon Feb 27 17:17:20 CST 2023, time=2023-02-27, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1241122, encodeId=aec712411227c, content=有没有投了被拒的，多长时间被拒？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201020/ab7dee8018d2436d9c185605ca6df4d1/259e5aca63734597994109f6badb5036.jpg, createdBy=e5255379558, createdName=丿柚子, createdTime=Fri Aug 26 11:01:31 CST 2022, time=2022-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233690, encodeId=286c123369024, content=两个月了还是in review , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af6a5287300, createdName=14856b50m82暂无昵称, createdTime=Wed Jul 20 20:44:37 CST 2022, time=2022-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2140610, encodeId=76cf214061019, content=审稿速度:24.0 | 投稿命中率:5.0<br>偏重的研究方向：心血管<br>经验分享：投稿9个多月，中间催稿三次，最后拒稿，说稿量太大，处理不过来，真是无语。搞不懂为何不早点拒稿，浪费别人时间，不建议投此期刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4e875572837, createdName=ms7000000342226604, createdTime=Sat Jun 03 10:46:59 CST 2023, time=2023-06-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1228408, encodeId=36c21228408c0, content=in review时间很长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbcb5705258, createdName=ms6000002029762274, createdTime=Fri Jun 24 12:03:23 CST 2022, time=2022-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127488, encodeId=4a3b212e488e4, content=2022年9月9号投稿，马上八个月了，还没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230421/adeb33fe5b714f0a8fb577ba825f7c91/e882373f4e104adeae042dac78711c17.jpg, createdBy=ea1a1836331, createdName=Lucky2023 , createdTime=Fri Apr 21 15:15:54 CST 2023, time=2023-04-21, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2115920, encodeId=6069211592029, content=审稿速度:12.0 | 投稿命中率:5.0<br>经验分享：2022年5月投稿，到现在9个月了，还是没有一审意见，这个期刊初审是不是要一整年啊，无语了，新的文章都已经发了好几篇了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2745723606, createdName=ms5000000402047516, createdTime=Wed Feb 22 14:05:24 CST 2023, time=2023-02-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2130098, encodeId=8ca42130098d2, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向：肿瘤;药理<br>经验分享：选刊比投稿更重要, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epmic7Il9IdkhKdPslSXbzCGyicssZvlek5wZt8vgWkKYUiabEWuAc0BmYZoYNFG8B7eCQdkia06oqnkQ/132, createdBy=c38f2021744, createdName=小舞SCI, createdTime=Thu May 04 19:54:03 CST 2023, time=2023-05-04, status=1, ipAttribution=江苏省)]
    2022-07-20 14856b50m82暂无昵称

    两个月了还是in review

    6

    展开6条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=1183540, encodeId=4669118354067, content=11月份投稿，一直到现在都是“In review”的状态。这个杂志是没有其他状态吗？还是就是这么慢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=31, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c0bc2138901, createdName=bpwen1989, createdTime=Wed Jan 12 15:25:17 CST 2022, time=2022-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097879, encodeId=0dec209e8792c, content=9月9号投稿，马上三个月了，一直是In review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230421/adeb33fe5b714f0a8fb577ba825f7c91/e882373f4e104adeae042dac78711c17.jpg, createdBy=ea1a1836331, createdName=ms1023144545986451, createdTime=Tue Nov 01 17:00:20 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116737, encodeId=379b2116e37c6, content=审稿速度:12.0 | 投稿命中率:5.0<br>经验分享：今天有消息了 ，刚好9个月，告诉我他们期刊这几年审稿压力很大，稿件量是三倍，还是没办法保证我的审稿，让我转投一个4分的期刊。大家慎重考虑此刊吧。<br>时间：投稿是2022年5月26日，在三个月、半年的时候分别催稿，第二次催稿回复我说文章正在外审，现在第9个月告诉我审不了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2745723606, createdName=ms5000000402047516, createdTime=Mon Feb 27 17:17:20 CST 2023, time=2023-02-27, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1241122, encodeId=aec712411227c, content=有没有投了被拒的，多长时间被拒？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201020/ab7dee8018d2436d9c185605ca6df4d1/259e5aca63734597994109f6badb5036.jpg, createdBy=e5255379558, createdName=丿柚子, createdTime=Fri Aug 26 11:01:31 CST 2022, time=2022-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233690, encodeId=286c123369024, content=两个月了还是in review , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af6a5287300, createdName=14856b50m82暂无昵称, createdTime=Wed Jul 20 20:44:37 CST 2022, time=2022-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2140610, encodeId=76cf214061019, content=审稿速度:24.0 | 投稿命中率:5.0<br>偏重的研究方向：心血管<br>经验分享：投稿9个多月，中间催稿三次，最后拒稿，说稿量太大，处理不过来，真是无语。搞不懂为何不早点拒稿，浪费别人时间，不建议投此期刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4e875572837, createdName=ms7000000342226604, createdTime=Sat Jun 03 10:46:59 CST 2023, time=2023-06-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1228408, encodeId=36c21228408c0, content=in review时间很长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbcb5705258, createdName=ms6000002029762274, createdTime=Fri Jun 24 12:03:23 CST 2022, time=2022-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127488, encodeId=4a3b212e488e4, content=2022年9月9号投稿，马上八个月了，还没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230421/adeb33fe5b714f0a8fb577ba825f7c91/e882373f4e104adeae042dac78711c17.jpg, createdBy=ea1a1836331, createdName=Lucky2023 , createdTime=Fri Apr 21 15:15:54 CST 2023, time=2023-04-21, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2115920, encodeId=6069211592029, content=审稿速度:12.0 | 投稿命中率:5.0<br>经验分享：2022年5月投稿，到现在9个月了，还是没有一审意见，这个期刊初审是不是要一整年啊，无语了，新的文章都已经发了好几篇了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2745723606, createdName=ms5000000402047516, createdTime=Wed Feb 22 14:05:24 CST 2023, time=2023-02-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2130098, encodeId=8ca42130098d2, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向：肿瘤;药理<br>经验分享：选刊比投稿更重要, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epmic7Il9IdkhKdPslSXbzCGyicssZvlek5wZt8vgWkKYUiabEWuAc0BmYZoYNFG8B7eCQdkia06oqnkQ/132, createdBy=c38f2021744, createdName=小舞SCI, createdTime=Thu May 04 19:54:03 CST 2023, time=2023-05-04, status=1, ipAttribution=江苏省)]
    2023-06-03 ms7000000342226604 来自广东省

    审稿速度:24.0 | 投稿命中率:5.0
    偏重的研究方向：心血管
    经验分享：投稿9个多月，中间催稿三次，最后拒稿，说稿量太大，处理不过来，真是无语。搞不懂为何不早点拒稿，浪费别人时间，不建议投此期刊。

    5

    展开5条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=1183540, encodeId=4669118354067, content=11月份投稿，一直到现在都是“In review”的状态。这个杂志是没有其他状态吗？还是就是这么慢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=31, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c0bc2138901, createdName=bpwen1989, createdTime=Wed Jan 12 15:25:17 CST 2022, time=2022-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097879, encodeId=0dec209e8792c, content=9月9号投稿，马上三个月了，一直是In review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230421/adeb33fe5b714f0a8fb577ba825f7c91/e882373f4e104adeae042dac78711c17.jpg, createdBy=ea1a1836331, createdName=ms1023144545986451, createdTime=Tue Nov 01 17:00:20 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116737, encodeId=379b2116e37c6, content=审稿速度:12.0 | 投稿命中率:5.0<br>经验分享：今天有消息了 ，刚好9个月，告诉我他们期刊这几年审稿压力很大，稿件量是三倍，还是没办法保证我的审稿，让我转投一个4分的期刊。大家慎重考虑此刊吧。<br>时间：投稿是2022年5月26日，在三个月、半年的时候分别催稿，第二次催稿回复我说文章正在外审，现在第9个月告诉我审不了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2745723606, createdName=ms5000000402047516, createdTime=Mon Feb 27 17:17:20 CST 2023, time=2023-02-27, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1241122, encodeId=aec712411227c, content=有没有投了被拒的，多长时间被拒？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201020/ab7dee8018d2436d9c185605ca6df4d1/259e5aca63734597994109f6badb5036.jpg, createdBy=e5255379558, createdName=丿柚子, createdTime=Fri Aug 26 11:01:31 CST 2022, time=2022-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233690, encodeId=286c123369024, content=两个月了还是in review , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af6a5287300, createdName=14856b50m82暂无昵称, createdTime=Wed Jul 20 20:44:37 CST 2022, time=2022-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2140610, encodeId=76cf214061019, content=审稿速度:24.0 | 投稿命中率:5.0<br>偏重的研究方向：心血管<br>经验分享：投稿9个多月，中间催稿三次，最后拒稿，说稿量太大，处理不过来，真是无语。搞不懂为何不早点拒稿，浪费别人时间，不建议投此期刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4e875572837, createdName=ms7000000342226604, createdTime=Sat Jun 03 10:46:59 CST 2023, time=2023-06-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1228408, encodeId=36c21228408c0, content=in review时间很长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbcb5705258, createdName=ms6000002029762274, createdTime=Fri Jun 24 12:03:23 CST 2022, time=2022-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127488, encodeId=4a3b212e488e4, content=2022年9月9号投稿，马上八个月了，还没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230421/adeb33fe5b714f0a8fb577ba825f7c91/e882373f4e104adeae042dac78711c17.jpg, createdBy=ea1a1836331, createdName=Lucky2023 , createdTime=Fri Apr 21 15:15:54 CST 2023, time=2023-04-21, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2115920, encodeId=6069211592029, content=审稿速度:12.0 | 投稿命中率:5.0<br>经验分享：2022年5月投稿，到现在9个月了，还是没有一审意见，这个期刊初审是不是要一整年啊，无语了，新的文章都已经发了好几篇了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2745723606, createdName=ms5000000402047516, createdTime=Wed Feb 22 14:05:24 CST 2023, time=2023-02-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2130098, encodeId=8ca42130098d2, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向：肿瘤;药理<br>经验分享：选刊比投稿更重要, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epmic7Il9IdkhKdPslSXbzCGyicssZvlek5wZt8vgWkKYUiabEWuAc0BmYZoYNFG8B7eCQdkia06oqnkQ/132, createdBy=c38f2021744, createdName=小舞SCI, createdTime=Thu May 04 19:54:03 CST 2023, time=2023-05-04, status=1, ipAttribution=江苏省)]
    2022-06-24 ms6000002029762274

    in review时间很长

    5

    展开5条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=1183540, encodeId=4669118354067, content=11月份投稿，一直到现在都是“In review”的状态。这个杂志是没有其他状态吗？还是就是这么慢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=31, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c0bc2138901, createdName=bpwen1989, createdTime=Wed Jan 12 15:25:17 CST 2022, time=2022-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097879, encodeId=0dec209e8792c, content=9月9号投稿，马上三个月了，一直是In review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230421/adeb33fe5b714f0a8fb577ba825f7c91/e882373f4e104adeae042dac78711c17.jpg, createdBy=ea1a1836331, createdName=ms1023144545986451, createdTime=Tue Nov 01 17:00:20 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116737, encodeId=379b2116e37c6, content=审稿速度:12.0 | 投稿命中率:5.0<br>经验分享：今天有消息了 ，刚好9个月，告诉我他们期刊这几年审稿压力很大，稿件量是三倍，还是没办法保证我的审稿，让我转投一个4分的期刊。大家慎重考虑此刊吧。<br>时间：投稿是2022年5月26日，在三个月、半年的时候分别催稿，第二次催稿回复我说文章正在外审，现在第9个月告诉我审不了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2745723606, createdName=ms5000000402047516, createdTime=Mon Feb 27 17:17:20 CST 2023, time=2023-02-27, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1241122, encodeId=aec712411227c, content=有没有投了被拒的，多长时间被拒？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201020/ab7dee8018d2436d9c185605ca6df4d1/259e5aca63734597994109f6badb5036.jpg, createdBy=e5255379558, createdName=丿柚子, createdTime=Fri Aug 26 11:01:31 CST 2022, time=2022-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233690, encodeId=286c123369024, content=两个月了还是in review , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af6a5287300, createdName=14856b50m82暂无昵称, createdTime=Wed Jul 20 20:44:37 CST 2022, time=2022-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2140610, encodeId=76cf214061019, content=审稿速度:24.0 | 投稿命中率:5.0<br>偏重的研究方向：心血管<br>经验分享：投稿9个多月，中间催稿三次，最后拒稿，说稿量太大，处理不过来，真是无语。搞不懂为何不早点拒稿，浪费别人时间，不建议投此期刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4e875572837, createdName=ms7000000342226604, createdTime=Sat Jun 03 10:46:59 CST 2023, time=2023-06-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1228408, encodeId=36c21228408c0, content=in review时间很长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbcb5705258, createdName=ms6000002029762274, createdTime=Fri Jun 24 12:03:23 CST 2022, time=2022-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127488, encodeId=4a3b212e488e4, content=2022年9月9号投稿，马上八个月了，还没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230421/adeb33fe5b714f0a8fb577ba825f7c91/e882373f4e104adeae042dac78711c17.jpg, createdBy=ea1a1836331, createdName=Lucky2023 , createdTime=Fri Apr 21 15:15:54 CST 2023, time=2023-04-21, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2115920, encodeId=6069211592029, content=审稿速度:12.0 | 投稿命中率:5.0<br>经验分享：2022年5月投稿，到现在9个月了，还是没有一审意见，这个期刊初审是不是要一整年啊，无语了，新的文章都已经发了好几篇了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2745723606, createdName=ms5000000402047516, createdTime=Wed Feb 22 14:05:24 CST 2023, time=2023-02-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2130098, encodeId=8ca42130098d2, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向：肿瘤;药理<br>经验分享：选刊比投稿更重要, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epmic7Il9IdkhKdPslSXbzCGyicssZvlek5wZt8vgWkKYUiabEWuAc0BmYZoYNFG8B7eCQdkia06oqnkQ/132, createdBy=c38f2021744, createdName=小舞SCI, createdTime=Thu May 04 19:54:03 CST 2023, time=2023-05-04, status=1, ipAttribution=江苏省)]
    2023-04-21 Lucky2023 来自四川省

    2022年9月9号投稿，马上八个月了，还没有消息

    4

    展开4条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=1183540, encodeId=4669118354067, content=11月份投稿，一直到现在都是“In review”的状态。这个杂志是没有其他状态吗？还是就是这么慢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=31, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c0bc2138901, createdName=bpwen1989, createdTime=Wed Jan 12 15:25:17 CST 2022, time=2022-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097879, encodeId=0dec209e8792c, content=9月9号投稿，马上三个月了，一直是In review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230421/adeb33fe5b714f0a8fb577ba825f7c91/e882373f4e104adeae042dac78711c17.jpg, createdBy=ea1a1836331, createdName=ms1023144545986451, createdTime=Tue Nov 01 17:00:20 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116737, encodeId=379b2116e37c6, content=审稿速度:12.0 | 投稿命中率:5.0<br>经验分享：今天有消息了 ，刚好9个月，告诉我他们期刊这几年审稿压力很大，稿件量是三倍，还是没办法保证我的审稿，让我转投一个4分的期刊。大家慎重考虑此刊吧。<br>时间：投稿是2022年5月26日，在三个月、半年的时候分别催稿，第二次催稿回复我说文章正在外审，现在第9个月告诉我审不了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2745723606, createdName=ms5000000402047516, createdTime=Mon Feb 27 17:17:20 CST 2023, time=2023-02-27, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1241122, encodeId=aec712411227c, content=有没有投了被拒的，多长时间被拒？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201020/ab7dee8018d2436d9c185605ca6df4d1/259e5aca63734597994109f6badb5036.jpg, createdBy=e5255379558, createdName=丿柚子, createdTime=Fri Aug 26 11:01:31 CST 2022, time=2022-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233690, encodeId=286c123369024, content=两个月了还是in review , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af6a5287300, createdName=14856b50m82暂无昵称, createdTime=Wed Jul 20 20:44:37 CST 2022, time=2022-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2140610, encodeId=76cf214061019, content=审稿速度:24.0 | 投稿命中率:5.0<br>偏重的研究方向：心血管<br>经验分享：投稿9个多月，中间催稿三次，最后拒稿，说稿量太大，处理不过来，真是无语。搞不懂为何不早点拒稿，浪费别人时间，不建议投此期刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4e875572837, createdName=ms7000000342226604, createdTime=Sat Jun 03 10:46:59 CST 2023, time=2023-06-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1228408, encodeId=36c21228408c0, content=in review时间很长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbcb5705258, createdName=ms6000002029762274, createdTime=Fri Jun 24 12:03:23 CST 2022, time=2022-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127488, encodeId=4a3b212e488e4, content=2022年9月9号投稿，马上八个月了，还没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230421/adeb33fe5b714f0a8fb577ba825f7c91/e882373f4e104adeae042dac78711c17.jpg, createdBy=ea1a1836331, createdName=Lucky2023 , createdTime=Fri Apr 21 15:15:54 CST 2023, time=2023-04-21, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2115920, encodeId=6069211592029, content=审稿速度:12.0 | 投稿命中率:5.0<br>经验分享：2022年5月投稿，到现在9个月了，还是没有一审意见，这个期刊初审是不是要一整年啊，无语了，新的文章都已经发了好几篇了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2745723606, createdName=ms5000000402047516, createdTime=Wed Feb 22 14:05:24 CST 2023, time=2023-02-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2130098, encodeId=8ca42130098d2, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向：肿瘤;药理<br>经验分享：选刊比投稿更重要, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epmic7Il9IdkhKdPslSXbzCGyicssZvlek5wZt8vgWkKYUiabEWuAc0BmYZoYNFG8B7eCQdkia06oqnkQ/132, createdBy=c38f2021744, createdName=小舞SCI, createdTime=Thu May 04 19:54:03 CST 2023, time=2023-05-04, status=1, ipAttribution=江苏省)]
    2023-02-22 ms5000000402047516 来自广东省

    审稿速度:12.0 | 投稿命中率:5.0
    经验分享：2022年5月投稿，到现在9个月了，还是没有一审意见，这个期刊初审是不是要一整年啊，无语了，新的文章都已经发了好几篇了

    4

    展开4条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=1183540, encodeId=4669118354067, content=11月份投稿，一直到现在都是“In review”的状态。这个杂志是没有其他状态吗？还是就是这么慢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=31, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c0bc2138901, createdName=bpwen1989, createdTime=Wed Jan 12 15:25:17 CST 2022, time=2022-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097879, encodeId=0dec209e8792c, content=9月9号投稿，马上三个月了，一直是In review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230421/adeb33fe5b714f0a8fb577ba825f7c91/e882373f4e104adeae042dac78711c17.jpg, createdBy=ea1a1836331, createdName=ms1023144545986451, createdTime=Tue Nov 01 17:00:20 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116737, encodeId=379b2116e37c6, content=审稿速度:12.0 | 投稿命中率:5.0<br>经验分享：今天有消息了 ，刚好9个月，告诉我他们期刊这几年审稿压力很大，稿件量是三倍，还是没办法保证我的审稿，让我转投一个4分的期刊。大家慎重考虑此刊吧。<br>时间：投稿是2022年5月26日，在三个月、半年的时候分别催稿，第二次催稿回复我说文章正在外审，现在第9个月告诉我审不了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2745723606, createdName=ms5000000402047516, createdTime=Mon Feb 27 17:17:20 CST 2023, time=2023-02-27, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1241122, encodeId=aec712411227c, content=有没有投了被拒的，多长时间被拒？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201020/ab7dee8018d2436d9c185605ca6df4d1/259e5aca63734597994109f6badb5036.jpg, createdBy=e5255379558, createdName=丿柚子, createdTime=Fri Aug 26 11:01:31 CST 2022, time=2022-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233690, encodeId=286c123369024, content=两个月了还是in review , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af6a5287300, createdName=14856b50m82暂无昵称, createdTime=Wed Jul 20 20:44:37 CST 2022, time=2022-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2140610, encodeId=76cf214061019, content=审稿速度:24.0 | 投稿命中率:5.0<br>偏重的研究方向：心血管<br>经验分享：投稿9个多月，中间催稿三次，最后拒稿，说稿量太大，处理不过来，真是无语。搞不懂为何不早点拒稿，浪费别人时间，不建议投此期刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4e875572837, createdName=ms7000000342226604, createdTime=Sat Jun 03 10:46:59 CST 2023, time=2023-06-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1228408, encodeId=36c21228408c0, content=in review时间很长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbcb5705258, createdName=ms6000002029762274, createdTime=Fri Jun 24 12:03:23 CST 2022, time=2022-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127488, encodeId=4a3b212e488e4, content=2022年9月9号投稿，马上八个月了，还没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230421/adeb33fe5b714f0a8fb577ba825f7c91/e882373f4e104adeae042dac78711c17.jpg, createdBy=ea1a1836331, createdName=Lucky2023 , createdTime=Fri Apr 21 15:15:54 CST 2023, time=2023-04-21, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2115920, encodeId=6069211592029, content=审稿速度:12.0 | 投稿命中率:5.0<br>经验分享：2022年5月投稿，到现在9个月了，还是没有一审意见，这个期刊初审是不是要一整年啊，无语了，新的文章都已经发了好几篇了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2745723606, createdName=ms5000000402047516, createdTime=Wed Feb 22 14:05:24 CST 2023, time=2023-02-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2130098, encodeId=8ca42130098d2, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向：肿瘤;药理<br>经验分享：选刊比投稿更重要, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epmic7Il9IdkhKdPslSXbzCGyicssZvlek5wZt8vgWkKYUiabEWuAc0BmYZoYNFG8B7eCQdkia06oqnkQ/132, createdBy=c38f2021744, createdName=小舞SCI, createdTime=Thu May 04 19:54:03 CST 2023, time=2023-05-04, status=1, ipAttribution=江苏省)]
    2023-05-04 小舞SCI 来自江苏省

    审稿速度:2.0 | 投稿命中率:75.0
    偏重的研究方向：肿瘤;药理
    经验分享：选刊比投稿更重要

    3

    展开3条回复
共119条页码: 1/12页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分